1-2 of 2
Bingyi Shi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First-in-Human Study of ET019003, a Next Generation Anti-CD19 T-Cell Therapy, in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma (r/r DLBCL)

Pengcheng He, Hong Liu, Haibo Liu, Mina Luo, Hui Feng, Qijing Li, Qi Chang, Bingyi Shi, Cheng Liu
Journal: Blood
Blood (2019) 134 (Supplement_1): 2870.
https://doi.org/10.1182/blood-2019-131414
Published: 2019
Journal Articles

mTOR masters monocyte development in bone marrow by decreasing the inhibition of STAT5 on IRF8

Yang Zhao, Xiaofei Shen, Ning Na, Zhulang Chu, Huiting Su, Shanshan Chao, Lu Shi, Yanan Xu, Lianfeng Zhang, Bingyi Shi, Yong Zhao
Journal: Blood
Blood (2018) 131 (14): 1587–1599.
https://doi.org/10.1182/blood-2017-04-777128
Published: 2018
Includes: Supplemental data